SciELO - Scientific Electronic Library Online

 
vol.133 número4Tratamiento endovascular del trauma de aorta descendenteEstudio de la actividad comparativa in vitro de telitromicina en patógenos respiratorios adquiridos en la comunidad en 13 centros clínicos chilenos índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

Compartilhar


Revista médica de Chile

versão impressa ISSN 0034-9887

Resumo

DUSSAILLANT N, Gastón et al. Frequency and characteristics of aspirin resistance in Chilean cardiovascular patients. Rev. méd. Chile [online]. 2005, vol.133, n.4, pp.409-417. ISSN 0034-9887.  http://dx.doi.org/10.4067/S0034-98872005000400003.

Background: Studies performed in Anglo-Saxon countries show that 5% of patients are resistant to the antiplatelet effects of aspirin. Aim: To assess the prevalence of aspirin resistance in a sample of Chilean cardiovascular patients and its association with clinical and laboratory characteristics. Patients and Methods: Ninety nine patients (30 women, 63±10 years) treated for stable cardiovascular diseases with aspirin 100-325 mg/day were studied. Clinical and basic coagulation variables were assessed. Platelet aggregation was studied with platelet rich plasma using three different agonists in an optical aggregometer. Aspirin resistance was defined as an aggregation 20% with arachidonic acid and an aggregation 70% with ADP or collagen. Results: Eleven patients (11.11%, 95% CI= 4.95-17.27%) complied with both criteria and were classified as aspirin resistant. Current smoking was more common in aspirin resistant patients (63.6 vs 29.6%, p=0.039). Conclusions: Aspirin resistance was found in a significant proportion of cardiovascular patients and was more common among current smokers

Palavras-chave : Aspirin; Cardiovascular diseases; Platelet aggregation inhibitors.

        · texto em Espanhol     · Espanhol ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons